nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—KCNH2—purkinje fiber—dilated cardiomyopathy	0.1	0.507	CbGeAlD
Prazosin—ABCB1—Lisinopril—dilated cardiomyopathy	0.0684	0.532	CbGbCtD
Prazosin—ABCB1—Spironolactone—dilated cardiomyopathy	0.0602	0.468	CbGbCtD
Prazosin—KCNH2—endocardium—dilated cardiomyopathy	0.0517	0.261	CbGeAlD
Prazosin—Antinuclear antibody positive—Lisinopril—dilated cardiomyopathy	0.0231	0.0717	CcSEcCtD
Prazosin—Incontinence—Furosemide—dilated cardiomyopathy	0.02	0.0621	CcSEcCtD
Prazosin—Vasculitis—Spironolactone—dilated cardiomyopathy	0.0132	0.0408	CcSEcCtD
Prazosin—MT3—heart—dilated cardiomyopathy	0.0131	0.0659	CbGeAlD
Prazosin—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0115	0.0357	CcSEcCtD
Prazosin—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00743	0.023	CcSEcCtD
Prazosin—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00719	0.0223	CcSEcCtD
Prazosin—Vasculitis—Furosemide—dilated cardiomyopathy	0.00717	0.0222	CcSEcCtD
Prazosin—Alopecia—Spironolactone—dilated cardiomyopathy	0.00571	0.0177	CcSEcCtD
Prazosin—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00538	0.0167	CcSEcCtD
Prazosin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00522	0.0162	CcSEcCtD
Prazosin—Malaise—Spironolactone—dilated cardiomyopathy	0.00507	0.0157	CcSEcCtD
Prazosin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00473	0.0147	CcSEcCtD
Prazosin—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00464	0.0144	CcSEcCtD
Prazosin—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.00435	0.022	CbGeAlD
Prazosin—Pancreatitis—Furosemide—dilated cardiomyopathy	0.0043	0.0133	CcSEcCtD
Prazosin—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00418	0.013	CcSEcCtD
Prazosin—KCNH2—myocardium—dilated cardiomyopathy	0.0041	0.0207	CbGeAlD
Prazosin—Somnolence—Spironolactone—dilated cardiomyopathy	0.00408	0.0126	CcSEcCtD
Prazosin—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00405	0.0126	CcSEcCtD
Prazosin—Drowsiness—Furosemide—dilated cardiomyopathy	0.00391	0.0121	CcSEcCtD
Prazosin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00378	0.0117	CcSEcCtD
Prazosin—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.00368	0.0186	CbGeAlD
Prazosin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00364	0.0113	CcSEcCtD
Prazosin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00363	0.0112	CcSEcCtD
Prazosin—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00348	0.0108	CcSEcCtD
Prazosin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00338	0.0105	CcSEcCtD
Prazosin—Tinnitus—Furosemide—dilated cardiomyopathy	0.00328	0.0102	CcSEcCtD
Prazosin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00325	0.0101	CcSEcCtD
Prazosin—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00323	0.01	CcSEcCtD
Prazosin—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00321	0.00995	CcSEcCtD
Prazosin—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00321	0.00995	CcSEcCtD
Prazosin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00314	0.00973	CcSEcCtD
Prazosin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00303	0.00941	CcSEcCtD
Prazosin—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00303	0.0094	CcSEcCtD
Prazosin—ADRA1A—heart—dilated cardiomyopathy	0.00296	0.0149	CbGeAlD
Prazosin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00292	0.00904	CcSEcCtD
Prazosin—Rash—Spironolactone—dilated cardiomyopathy	0.00289	0.00897	CcSEcCtD
Prazosin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00289	0.00896	CcSEcCtD
Prazosin—Vision blurred—Furosemide—dilated cardiomyopathy	0.00288	0.00894	CcSEcCtD
Prazosin—Headache—Spironolactone—dilated cardiomyopathy	0.00287	0.00891	CcSEcCtD
Prazosin—KCNH2—heart—dilated cardiomyopathy	0.00286	0.0144	CbGeAlD
Prazosin—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00277	0.00859	CcSEcCtD
Prazosin—Vertigo—Furosemide—dilated cardiomyopathy	0.00275	0.00852	CcSEcCtD
Prazosin—Nausea—Spironolactone—dilated cardiomyopathy	0.00272	0.00845	CcSEcCtD
Prazosin—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00268	0.00832	CcSEcCtD
Prazosin—Hallucination—Lisinopril—dilated cardiomyopathy	0.00262	0.00813	CcSEcCtD
Prazosin—Dry mouth—Furosemide—dilated cardiomyopathy	0.00255	0.00789	CcSEcCtD
Prazosin—ABCG2—heart—dilated cardiomyopathy	0.00254	0.0128	CbGeAlD
Prazosin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00246	0.00762	CcSEcCtD
Prazosin—Shock—Furosemide—dilated cardiomyopathy	0.00246	0.00761	CcSEcCtD
Prazosin—Flushing—Lisinopril—dilated cardiomyopathy	0.00245	0.00758	CcSEcCtD
Prazosin—KCNH2—cardiac atrium—dilated cardiomyopathy	0.00244	0.0123	CbGeAlD
Prazosin—CYP1A1—heart—dilated cardiomyopathy	0.00241	0.0122	CbGeAlD
Prazosin—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00241	0.00748	CcSEcCtD
Prazosin—Alopecia—Lisinopril—dilated cardiomyopathy	0.00233	0.00722	CcSEcCtD
Prazosin—Tension—Lisinopril—dilated cardiomyopathy	0.00225	0.00698	CcSEcCtD
Prazosin—ADRA2A—heart—dilated cardiomyopathy	0.00225	0.0114	CbGeAlD
Prazosin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00224	0.00695	CcSEcCtD
Prazosin—Nervousness—Lisinopril—dilated cardiomyopathy	0.00223	0.00691	CcSEcCtD
Prazosin—Somnolence—Furosemide—dilated cardiomyopathy	0.00222	0.00688	CcSEcCtD
Prazosin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00216	0.0067	CcSEcCtD
Prazosin—Fatigue—Furosemide—dilated cardiomyopathy	0.00215	0.00667	CcSEcCtD
Prazosin—Pain—Furosemide—dilated cardiomyopathy	0.00213	0.00662	CcSEcCtD
Prazosin—Constipation—Furosemide—dilated cardiomyopathy	0.00213	0.00662	CcSEcCtD
Prazosin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00213	0.0066	CcSEcCtD
Prazosin—Malaise—Lisinopril—dilated cardiomyopathy	0.00207	0.00642	CcSEcCtD
Prazosin—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.00206	0.0104	CbGeAlD
Prazosin—Vertigo—Lisinopril—dilated cardiomyopathy	0.00206	0.00639	CcSEcCtD
Prazosin—Syncope—Lisinopril—dilated cardiomyopathy	0.00206	0.00638	CcSEcCtD
Prazosin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00206	0.00638	CcSEcCtD
Prazosin—Palpitations—Lisinopril—dilated cardiomyopathy	0.00203	0.00629	CcSEcCtD
Prazosin—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00202	0.00625	CcSEcCtD
Prazosin—Urticaria—Furosemide—dilated cardiomyopathy	0.00198	0.00615	CcSEcCtD
Prazosin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00197	0.00612	CcSEcCtD
Prazosin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00195	0.00606	CcSEcCtD
Prazosin—Discomfort—Lisinopril—dilated cardiomyopathy	0.00193	0.00598	CcSEcCtD
Prazosin—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00192	0.00972	CbGeAlD
Prazosin—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00191	0.00592	CcSEcCtD
Prazosin—Oedema—Lisinopril—dilated cardiomyopathy	0.00187	0.00581	CcSEcCtD
Prazosin—Shock—Lisinopril—dilated cardiomyopathy	0.00184	0.00571	CcSEcCtD
Prazosin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00184	0.0057	CcSEcCtD
Prazosin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00183	0.00567	CcSEcCtD
Prazosin—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00181	0.00561	CcSEcCtD
Prazosin—Asthenia—Furosemide—dilated cardiomyopathy	0.00179	0.00555	CcSEcCtD
Prazosin—Pruritus—Furosemide—dilated cardiomyopathy	0.00177	0.00547	CcSEcCtD
Prazosin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00171	0.00529	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00171	0.00529	CcSEcCtD
Prazosin—Insomnia—Lisinopril—dilated cardiomyopathy	0.00169	0.00525	CcSEcCtD
Prazosin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00168	0.00521	CcSEcCtD
Prazosin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00167	0.00518	CcSEcCtD
Prazosin—Somnolence—Lisinopril—dilated cardiomyopathy	0.00166	0.00516	CcSEcCtD
Prazosin—Dizziness—Furosemide—dilated cardiomyopathy	0.00165	0.00512	CcSEcCtD
Prazosin—Fatigue—Lisinopril—dilated cardiomyopathy	0.00161	0.00501	CcSEcCtD
Prazosin—Constipation—Lisinopril—dilated cardiomyopathy	0.0016	0.00497	CcSEcCtD
Prazosin—Pain—Lisinopril—dilated cardiomyopathy	0.0016	0.00497	CcSEcCtD
Prazosin—Vomiting—Furosemide—dilated cardiomyopathy	0.00159	0.00492	CcSEcCtD
Prazosin—Rash—Furosemide—dilated cardiomyopathy	0.00157	0.00488	CcSEcCtD
Prazosin—Dermatitis—Furosemide—dilated cardiomyopathy	0.00157	0.00487	CcSEcCtD
Prazosin—Headache—Furosemide—dilated cardiomyopathy	0.00156	0.00485	CcSEcCtD
Prazosin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00154	0.00478	CcSEcCtD
Prazosin—Urticaria—Lisinopril—dilated cardiomyopathy	0.00149	0.00461	CcSEcCtD
Prazosin—Nausea—Furosemide—dilated cardiomyopathy	0.00148	0.0046	CcSEcCtD
Prazosin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00148	0.00459	CcSEcCtD
Prazosin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00138	0.00428	CcSEcCtD
Prazosin—Asthenia—Lisinopril—dilated cardiomyopathy	0.00134	0.00417	CcSEcCtD
Prazosin—Pruritus—Lisinopril—dilated cardiomyopathy	0.00132	0.00411	CcSEcCtD
Prazosin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00128	0.00397	CcSEcCtD
Prazosin—ABCB1—heart—dilated cardiomyopathy	0.00125	0.00633	CbGeAlD
Prazosin—Dizziness—Lisinopril—dilated cardiomyopathy	0.00124	0.00384	CcSEcCtD
Prazosin—Vomiting—Lisinopril—dilated cardiomyopathy	0.00119	0.00369	CcSEcCtD
Prazosin—Rash—Lisinopril—dilated cardiomyopathy	0.00118	0.00366	CcSEcCtD
Prazosin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00118	0.00366	CcSEcCtD
Prazosin—Headache—Lisinopril—dilated cardiomyopathy	0.00117	0.00364	CcSEcCtD
Prazosin—Nausea—Lisinopril—dilated cardiomyopathy	0.00111	0.00345	CcSEcCtD
Prazosin—HTR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000146	0.000417	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000146	0.000415	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000145	0.000415	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000145	0.000413	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	0.000145	0.000413	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000145	0.000412	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—CD36—dilated cardiomyopathy	0.000144	0.000411	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000143	0.000408	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000142	0.000404	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000141	0.000401	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00014	0.000399	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000139	0.000397	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000139	0.000397	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	0.000139	0.000397	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000138	0.000392	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000138	0.000392	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000137	0.000391	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000137	0.00039	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000136	0.000389	CbGpPWpGaD
Prazosin—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000136	0.000388	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000136	0.000388	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000136	0.000387	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—RAC1—dilated cardiomyopathy	0.000136	0.000387	CbGpPWpGaD
Prazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000136	0.000386	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000133	0.00038	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000133	0.000378	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000133	0.000378	CbGpPWpGaD
Prazosin—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000133	0.000378	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000132	0.000375	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00013	0.00037	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	0.00013	0.00037	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000129	0.000369	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000129	0.000368	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000128	0.000365	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.000128	0.000365	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000128	0.000364	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000126	0.00036	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000126	0.00036	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000125	0.000357	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000124	0.000353	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000124	0.000353	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000124	0.000353	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000123	0.000352	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000122	0.000349	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00012	0.000341	CbGpPWpGaD
Prazosin—SLC22A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000119	0.00034	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000118	0.000338	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000118	0.000338	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000118	0.000335	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000117	0.000334	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000116	0.000332	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	0.000116	0.00033	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000115	0.000328	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000115	0.000328	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000115	0.000328	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000114	0.000324	CbGpPWpGaD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000113	0.000321	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000112	0.00032	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000112	0.00032	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000112	0.00032	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000111	0.000317	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000111	0.000317	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000111	0.000316	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000111	0.000315	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00011	0.000314	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000109	0.000311	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000107	0.000305	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000107	0.000305	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000107	0.000304	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000106	0.000302	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000106	0.000301	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000105	0.0003	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000105	0.0003	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000104	0.000298	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000104	0.000297	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000104	0.000297	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000103	0.000295	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000103	0.000294	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000103	0.000293	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000102	0.000291	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000102	0.00029	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000101	0.000289	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000101	0.000288	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000101	0.000287	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.0001	0.000286	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.0001	0.000285	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.78e-05	0.000279	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.73e-05	0.000277	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.7e-05	0.000277	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.69e-05	0.000276	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—AGT—dilated cardiomyopathy	9.63e-05	0.000275	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.51e-05	0.000271	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.5e-05	0.000271	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.47e-05	0.00027	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9.4e-05	0.000268	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.23e-05	0.000263	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—GPX1—dilated cardiomyopathy	9.18e-05	0.000262	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.15e-05	0.000261	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.08e-05	0.000259	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.02e-05	0.000257	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	9e-05	0.000257	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	9e-05	0.000257	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	9e-05	0.000257	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—CD36—dilated cardiomyopathy	8.94e-05	0.000255	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.85e-05	0.000252	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.84e-05	0.000252	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.84e-05	0.000252	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.64e-05	0.000246	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.63e-05	0.000246	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.62e-05	0.000246	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.58e-05	0.000244	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.41e-05	0.00024	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.39e-05	0.000239	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.37e-05	0.000238	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.28e-05	0.000236	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	8.25e-05	0.000235	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.2e-05	0.000234	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.2e-05	0.000234	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.13e-05	0.000232	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.13e-05	0.000232	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.11e-05	0.000231	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.09e-05	0.00023	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—AGT—dilated cardiomyopathy	8.05e-05	0.000229	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.03e-05	0.000229	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.91e-05	0.000225	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.89e-05	0.000225	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.85e-05	0.000224	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.85e-05	0.000224	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.79e-05	0.000222	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.76e-05	0.000221	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.67e-05	0.000219	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.61e-05	0.000217	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.56e-05	0.000215	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.56e-05	0.000215	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.54e-05	0.000215	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.52e-05	0.000214	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.48e-05	0.000213	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.47e-05	0.000213	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.47e-05	0.000213	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.47e-05	0.000213	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	7.44e-05	0.000212	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.32e-05	0.000209	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.29e-05	0.000208	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	7.19e-05	0.000205	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.16e-05	0.000204	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.06e-05	0.000201	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	7.06e-05	0.000201	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.01e-05	0.0002	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.98e-05	0.000199	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.95e-05	0.000198	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.94e-05	0.000198	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.92e-05	0.000197	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	6.84e-05	0.000195	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	6.83e-05	0.000195	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.73e-05	0.000192	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	6.72e-05	0.000192	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.69e-05	0.000191	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.69e-05	0.000191	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.64e-05	0.000189	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.64e-05	0.000189	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.59e-05	0.000188	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.57e-05	0.000187	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.51e-05	0.000185	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.36e-05	0.000181	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.25e-05	0.000178	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.22e-05	0.000177	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.17e-05	0.000176	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.17e-05	0.000176	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.17e-05	0.000176	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	6.08e-05	0.000173	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.03e-05	0.000172	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.98e-05	0.00017	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	5.96e-05	0.00017	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.93e-05	0.000169	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.91e-05	0.000168	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	5.82e-05	0.000166	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	5.76e-05	0.000164	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.75e-05	0.000164	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.73e-05	0.000163	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.72e-05	0.000163	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.72e-05	0.000163	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	5.69e-05	0.000162	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CD36—dilated cardiomyopathy	5.67e-05	0.000162	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	5.65e-05	0.000161	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.64e-05	0.000161	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	5.61e-05	0.00016	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.55e-05	0.000158	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.45e-05	0.000155	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	5.37e-05	0.000153	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	5.23e-05	0.000149	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.17e-05	0.000147	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—AGT—dilated cardiomyopathy	5.1e-05	0.000145	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.1e-05	0.000145	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	5.1e-05	0.000145	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.09e-05	0.000145	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	5.05e-05	0.000144	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.99e-05	0.000142	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.92e-05	0.00014	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	4.87e-05	0.000139	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.84e-05	0.000138	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.75e-05	0.000135	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.74e-05	0.000135	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	4.71e-05	0.000134	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.68e-05	0.000133	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	4.6e-05	0.000131	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.59e-05	0.000131	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	4.55e-05	0.00013	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.5e-05	0.000128	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.44e-05	0.000127	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	4.43e-05	0.000126	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	4.4e-05	0.000125	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	4.25e-05	0.000121	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	4.23e-05	0.000121	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.22e-05	0.00012	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.16e-05	0.000119	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.09e-05	0.000117	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	4.04e-05	0.000115	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	3.99e-05	0.000114	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	3.95e-05	0.000113	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	3.94e-05	0.000112	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.92e-05	0.000112	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.92e-05	0.000112	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.87e-05	0.00011	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	3.84e-05	0.000109	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.76e-05	0.000107	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	3.59e-05	0.000102	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.54e-05	0.000101	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.49e-05	9.95e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	3.45e-05	9.84e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.42e-05	9.75e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	3.38e-05	9.63e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.34e-05	9.51e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.26e-05	9.28e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.15e-05	8.97e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.06e-05	8.73e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.05e-05	8.7e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.95e-05	8.4e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.89e-05	8.24e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.81e-05	8e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.76e-05	7.86e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	2.71e-05	7.72e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.69e-05	7.66e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.49e-05	7.1e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	2.32e-05	6.61e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.32e-05	6.6e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.09e-05	5.96e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.02e-05	5.76e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.92e-05	5.48e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.71e-05	4.87e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.59e-05	4.52e-05	CbGpPWpGaD
